Annual Operating Expenses
$6.86 M
+$4.54 M+196.02%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual total operating expenses is $6.86 million, with the most recent change of +$4.54 million (+196.02%) on December 31, 2023.
- During the last 3 years, CHRO annual operating expenses has risen by +$5.31 million (+341.65%).
- CHRO annual operating expenses is now at all-time high.
Performance
CHRO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.05 M
+$284.25 K+16.11%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly total operating expenses is $2.05 million, with the most recent change of +$284.25 thousand (+16.11%) on September 30, 2024.
- Over the past year, CHRO quarterly operating expenses has dropped by -$1.83 million (-47.19%).
- CHRO quarterly operating expenses is now -47.19% below its all-time high of $3.88 million, reached on December 31, 2023.
Performance
CHRO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CHRO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +196.0% | -47.2% |
| 3 y3 years | +341.6% | +294.8% |
| 5 y5 years | +341.6% | +294.8% |
CHRO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +717.9% | -47.2% | +875.4% |
| 5 y | 5-year | at high | +717.9% | -47.2% | +875.4% |
| alltime | all time | at high | +717.9% | -47.2% | +875.4% |
Chromocell Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.05 M(+16.1%) |
| Jun 2024 | - | $1.76 M(-8.8%) |
| Mar 2024 | - | $1.93 M(-50.1%) |
| Dec 2023 | $6.86 M | $3.88 M(+200.3%) |
| Sep 2023 | - | $1.29 M(+66.2%) |
| Jun 2023 | - | $777.20 K(-15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $914.60 K(-24.7%) |
| Dec 2022 | $2.32 M(+176.3%) | $1.21 M(+134.2%) |
| Sep 2022 | - | $518.80 K(+74.9%) |
| Jun 2022 | - | $296.70 K(+3.1%) |
| Mar 2022 | - | $287.80 K(+37.0%) |
| Dec 2021 | $839.00 K(-46.0%) | $210.00 K |
| Dec 2020 | $1.55 M | - |
FAQ
- What is Chromocell Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual operating expenses year-on-year change?
- What is Chromocell Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly operating expenses year-on-year change?
What is Chromocell Therapeutics annual total operating expenses?
The current annual operating expenses of CHRO is $6.86 M
What is the all time high annual operating expenses for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual total operating expenses is $6.86 M
What is Chromocell Therapeutics annual operating expenses year-on-year change?
Over the past year, CHRO annual total operating expenses has changed by +$4.54 M (+196.02%)
What is Chromocell Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CHRO is $2.05 M
What is the all time high quarterly operating expenses for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly total operating expenses is $3.88 M
What is Chromocell Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CHRO quarterly total operating expenses has changed by -$1.83 M (-47.19%)